Matti Waris
mwaris@utu.fi +358 29 450 4553 +358 46 921 4088 Kiinamyllynkatu 10 Turku ORCID identifier: https://orcid.org/0000-0002-6747-0889 |
Areas of expertise
Virology, molecular diagnostics, immunology of viral infections
Virology, molecular diagnostics, immunology of viral infections
Publications
- Uuden SARS-CoV-2-koronaviruksen laboratoriodiagnostiikka (2020)
- Erikoislääkäri
(D1 Article in a professional journal) - Acute respiratory infections in early childhood and risk of asthma at age 7 years (2019)
- Journal of Allergy and Clinical Immunology
(A1 Refereed original research article in a scientific journal) - Common cold in Team Finland during 2018 Winter Olympic Games (PyeongChang): Epidemiology, diagnosis including molecular point-of-care testing (POCT) and treatment (2019)
- British Journal of Sports Medicine
(A1 Refereed original research article in a scientific journal) - Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010–2015 (2019)
- Journal of Infection
(A1 Refereed original research article in a scientific journal) - Early nasal microbiota and acute respiratory infections during the first years of life (2019)
- Thorax
(A1 Refereed original research article in a scientific journal) - Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age (2019)
- Vaccine
(A1 Refereed original research article in a scientific journal) - Flunssa (2019) Lasten infektiosairaudet Terho Heikkinen, Matti Waris, Olli Ruuskanen
(D2 Article in a professional compilation book) - Influenza virus infections from 0 to 2 years of age: A birth cohort study (2019)
- Journal of Microbiology, Immunology and Infection
(A1 Refereed original research article in a scientific journal) - Introducing a New Algorithm for Classification of Etiology in Studies on Pediatric Pneumonia: Protocol for the Trial of Respiratory Infections in Children for Enhanced Diagnostics Study (2019)
- JMIR Research Protocols
(A1 Refereed original research article in a scientific journal) - MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis (2019)
- Rheumatology
(B1 Non-refereed article in a scientific journal)



